Physician profile
J Mocco
NPI 1144425067
$1,600,726.74
in general payments reported to CMS, 2019-2025
31 companies · $201K in 2025
The $201K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547K · 2020: $87K · 2021: $34K · 2022: $141K · 2023: $317K · 2024: $274K · 2025: $201K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $650K · Acquisitions: $77K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Food and Beverage: $5,830 · Travel and Lodging: $3,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $649,512.52 |
| Acquisitions | $76,675.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56,890.32 |
| Food and Beverage | $5,829.97 |
| Travel and Lodging | $3,517.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $672,811.52 | 2019-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter, Zoom Reperfusion Catheter |
| Corindus INC. | $528,149.37 | 2019 | |
| Medtronic, INC. | $147,028.72 | 2021-2025 | Rist, Pipeline, Solitaire X |
| Medtronic USA, INC. | $82,613.06 | 2019-2020 | |
| Nico Corporation | $75,000.00 | 2024 | |
| Kaneka Medical America LLC | $28,890.32 | 2025 | Apheresis Machine |
| Irras USA, INC. | $27,670.14 | 2021-2025 | Irraflow |
| Philips North America LLC | $12,942.02 | 2022-2025 | Ultrasound Enabling Functions |
| Boston Scientific Corporation | $8,388.44 | 2019-2020 | |
| Microvention, INC. | $3,105.14 | 2019-2024 | Phil, Balloon Catheter, Eric Retrieval Device |
| Viseon, INC. | $3,000.00 | 2023 | Maxview System - Lateral Set |
| Btg International INC. | $2,500.00 | 2025 | |
| Stryker Corporation | $1,863.87 | 2019-2023 | Target |
| Integra Lifesciences Corporation | $1,496.66 | 2019-2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Medical Device Business Services, INC. | $1,383.61 | 2019-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $896.63 | 2019-2022 | |
| Balt USA, LLC | $653.81 | 2023-2024 | Optima Coil System, Prestige Coil System |
| Depuy Synthes Sales INC. | $618.33 | 2019-2024 | Cerepak Uniform |
| Inspiremd Ltd | $363.00 | 2023-2024 | Cguard, Cguard |
| Penumbra, INC. | $319.64 | 2019-2025 | Penumbra System |
| Asahi Intecc Co., Ltd. | $316.33 | 2023 | |
| Scientia Vascular | $270.21 | 2022-2023 | |
| Microtransponder, INC. | $258.62 | 2025 | |
| Elekta, INC. | $161.83 | 2021 | |
| Cook Medical LLC | $22.83 | 2019 | |
| Phenox INC. | $2.64 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$76,490,651.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Mocco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.